Fast Five Quiz: Genetics of Non–Small Cell Lung Cancer

Daniel S. Schwartz, MD, MBA

Disclosures

February 03, 2021

Research on the genetics of non–small cell lung cancer (NSCLC) has led to targeted therapies and immunotherapies that have been shown to reduce progression to metastatic disease. Several mutations and genomic aberrations are predictive of a patient's therapeutic responses to particular agents and should therefore be considered during treatment planning.

How much do you know about the genetics of NSCLC? Check your knowledge with this quick quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....